Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_assertion description "[At the moment the most promising parameters for future trials and treatment decisions seem to be the plasma cell labeling index, the beta2-microglobulin and hopefully cytogenetic abnormalities that are detectable in multiple myeloma now using newer cultivation methods and fluorescence in situ hybridization in interphase plasma cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_assertion evidence source_evidence_literature NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_assertion SIO_000772 9436931 NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_assertion wasDerivedFrom befree-20140225 NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_assertion wasGeneratedBy ECO_0000203 NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.
- befree-20140225 importedOn "2014-02-25" NP912476.RAAVy3-Dd2llNJN4c7cpXoQ1Sw2b6P3Z032cmB5SBrBhM130_provenance.